Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2004
07/15/2004US20040138105 Modulators of polysaccharides and uses thereof
07/15/2004US20040138094 Disease caused by peroxisome proliferator activator receptors ; administering moderator; anticholesterol agents
07/15/2004US20040137644 Using immunoglobulin conjugated metal collloid and laser excitation to target and destroy cells, parasites, infected tissues and/or microrganism; propidium iodide staining
07/15/2004US20040137643 Using receptor specific immunoglobulins to identify cytochrome P450-dependent monooxygenases (P450s) for use as tools in xenobiotic drug design; high throughput assay
07/15/2004US20040137641 Kit comprising porous membrane for detecting glycated blood products; monitoring blood glucose level of diabetics
07/15/2004US20040137640 Flexible, porous sheet comprising support film for capure and analysis of bodily fluids and blood components; medicinal diagnostics
07/15/2004US20040137636 Sulfuryl fluoride fumigation process
07/15/2004US20040137633 for increasing accuracy and effective life span of an electrochemical sensor system with oxygen-containing calibration solutions
07/15/2004US20040137620 Compositions corresponding to a calcium transporter and methods of making and using same
07/15/2004US20040137617 Purification of antigen-specific T cells
07/15/2004US20040137614 Human ovarian mesothelial cells and methods of isolation and uses thereof
07/15/2004US20040137608 comprises multiple wells in a solid support and a plurality of likers attached to the wells; solid phase synthesis; chemical libraries; for drug screening
07/15/2004US20040137607 Microfluidic apparatus comprising microarray for monitoring and analyzing associations between biopolymers
07/15/2004US20040137597 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates
07/15/2004US20040137595 Mfq-111, a novel human gtpase like protein
07/15/2004US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits
07/15/2004US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis
07/15/2004US20040137563 Endogenous and non-endogenous versions of human G protein-coupled receptors
07/15/2004US20040137553 Enzymic microassay for measurement of chlorite, chlorate and perchlorate
07/15/2004US20040137552 kits for quantitative determination of differential protein expression and/or modification in different samples; solid phase synthesis
07/15/2004US20040137551 Cervical acid phosphatase - papanicolaou (CAP-PAP) test kit, method and accesories, processes for producing and using the same
07/15/2004US20040137549 Diagnostic and examination method for cancer of the colon using tannase as indication
07/15/2004US20040137548 for drug screening microbiocides; acyl carrier protein mixtures; enzyme inhibitors
07/15/2004US20040137546 Method for determination of free and combined glycerin in biodiesel
07/15/2004US20040137544 PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
07/15/2004US20040137543 Bacteriotoxin adsorbents and method of screening the same
07/15/2004US20040137542 for assessing the risk of an individual of suffering from atherosclerosis by detecting anti-lipoprotein immune complexes using immunoglobulin binding protein (protein A); solid phase synthesis; kits
07/15/2004US20040137541 determining the prognosis of and monitoring cancers, including gynecological cancers such as ovarian, uterine, fallopian tube and cervical cancers, correlated with elevated concentrations of certain lysophospholipids
07/15/2004US20040137539 based on detected levels of biomolecular markers (BMMs) associated with a patient's tumor; for diagnosis/prognosis
07/15/2004US20040137538 based on detected levels of biomolecular markers (BMMs) associated with a patient's tumor; for diagnosis/prognosis
07/15/2004US20040137537 Methods and systems for detecting MHC class I and II binding peptides
07/15/2004US20040137536 Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel
07/15/2004US20040137535 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
07/15/2004US20040137534 Methods for detecting deantigenized T cell epitopes and uses thereof
07/15/2004US20040137533 useful as adjuncts in myocardiological perfusion imaging by administering a radionuclide; for determining areas of insufficient blood flow; adenosine receptor
07/15/2004US20040137532 Antibody competition test (act) for the qualitative and conformation dependent quantitative detection of the conformation changes of p-glycoprotein and other cell surface receptors, pumps and proteins, and uses thereof
07/15/2004US20040137531 Methods of screening for inhibitors of phospholipid synthesis related to glycolipid-storage diseases
07/15/2004US20040137530 for diagnostic assays/genetically engineering drugs and vaccines
07/15/2004US20040137529 Identifying prions in infectious conformations in mammalian nervous system tissue; diagnosing spongiform encephalopathies in animals
07/15/2004US20040137528 Fragments of fluorescent proteins for protein fragment complementation assays
07/15/2004US20040137526 first, second and third seperation of multiple polypeptides in a sample depends on charging, hydrophobicity and size accordingly
07/15/2004US20040137525 Detection of salmonella cells by fluorescence polarization
07/15/2004US20040137524 of probes in cell detection and measurement systems; uses Acid Black 48 as an effective quencher
07/15/2004US20040137523 Method of isolation and self-assembly of small protein particles from blood and other biological materials
07/15/2004US20040137522 Genes and proteins altering Tau-related neurodegeneration
07/15/2004US20040137521 Method for apo clll measurement in apo b and non apo b containing particles
07/15/2004US20040137520 non-invasive; using urine, saliva, semen, perspiration, mucous, blood, plasma and serum samples; kits
07/15/2004US20040137519 Method for localizing and identifying epitopes
07/15/2004US20040137518 CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAME
07/15/2004US20040137517 for G-protein coupled receptor (GPCR) competitive inhibitor drugs; utilizing fatty acids
07/15/2004US20040137516 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides
07/15/2004US20040137515 Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample
07/15/2004US20040137514 Use of antibodies against specific mhc-peptide complexes
07/15/2004US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits
07/15/2004US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells
07/15/2004US20040137492 Novel polypeptide
07/15/2004US20040137489 through comparative global WNT gene signaling antagonist expression profiling (soluble frizzled related protein 3 (SFRP-3/FRZB) or human homologue of Dickkopf-1 (DKK1)); gene expression inhibition
07/15/2004US20040137486 correlates known sensory, physical, ingredient, or processing properties (color, taste, texture, pH, moisture content) with a spectrum of target species of microorganisms that are present
07/15/2004US20040137484 Nucleic acid amplification methods
07/15/2004US20040137481 Artificial receptor building blocks, components, and kits
07/15/2004US20040137480 comprises a fusion protein comprising a beta-galactosidase enzyme donor oligopeptide fused to a surrogate protein; gene expression inhibition; for diagnosis/therapy; kits
07/15/2004US20040137479 Compositions and methods for visual ribonuclease detection assays
07/15/2004US20040137478 that use whispering gallery modes (WGMs) by having receptors selectively substantially provided at only an equator region, formed of a relative high infrared material, and/or having a relatively small radius
07/15/2004US20040137477 A3AR as a marker for a diseased state
07/15/2004US20040137475 nucleic acid or a poly(amino acid) samples and dyes in form of staining solution are combined for sufficient time to form dye-analyte complex and are illuminated with an appropriate wavelength whereby nucleic acid or a poly(amino acid) is detected
07/15/2004US20040137472 identifying a compound capable of modulating a splicing event in a pre-mRNA molecule using a cDNA incapable of gene expression in the absence of modulation of a splicing event; using compound(s) identified to treat genetic disorders
07/15/2004US20040137468 Solid phase based nucleic acid assays combining high affinity and high specificity
07/15/2004US20040137457 Method
07/15/2004US20040137455 Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene
07/15/2004US20040137452 Diagnostic test
07/15/2004US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2
07/15/2004US20040137447 Human sphingosine-1-phosphate phosphatase
07/15/2004US20040137446 Fab I and inhibition of apicomplexan parasites
07/15/2004US20040137445 Microchip liquid chromatography; injections are made by electro-osmotically pumping sample through the injection channel that crosses the separation channel, followed by a switching of the potentials to force a plug into the separation channel
07/15/2004US20040137435 Human abc transporter expressed in liver,atil
07/15/2004US20040137430 Contacting sample with bacteriophage comprising a binding agent (biotin) , incubating and allowing complex to form; substrate comprising immobilized ligand (streptavidin)
07/15/2004US20040137428 Contacting the sample with a plurality of ligands such as oligosaccharide, siderophore, aferrisiderophore, and a vitamin; detecting binding to the surface of the solid suppot; iron-chelating agent
07/15/2004US20040137427 Retentate chromatography and protein chip arrays with applications in biology and medicine
07/15/2004US20040137425 Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays
07/15/2004US20040137421 Deposition of the protein in the follicular dendritic cell of a non-human animal and detection by histology, electrophoresis or binding assay
07/15/2004US20040137420 Irradiating a laser to a intracellular region and analyzing the mass ions; determining the chemical structure by correlating with molecular weight; matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
07/15/2004US20040137164 photopolymerization; improved hemocompatability, wettability/hydrophilicity, durability, biocompatability, and bacterial adhesion
07/15/2004US20040137141 Solution drying system
07/15/2004US20040137137 comprises ethanol aqueous solution in the presence of 2-mercaptoethanol and decoupling agent (urea), in phosphate buffer; for analysis of foods for celiac sufferers
07/15/2004US20040137011 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
07/15/2004US20040137005 Chlamydia protein, sequence and uses thereof
07/15/2004US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
07/15/2004US20040136997 Identification and development of specific monoclonal antibodies to squamous cell carcinoma
07/15/2004US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106
07/15/2004US20040136993 inducing an immunogenic response against alpha-SN
07/15/2004US20040136953 diagnosing aggressive form of respiratory condition by a different T helper cell response when samples are incubated with antigen characteristic of condition; treatment with interferon gamma
07/15/2004US20040136910 Differentiating tumors from healthy cells by placing the marker-folate conjugate in contact with excised or in vivo tissue and viewing
07/15/2004US20040136875 Chips in fluid confinement regions
07/15/2004US20040136874 Detection gases in sample using photometers ; permselective membranes; decomposition; purification
07/15/2004US20040136872 NOx monitor using differential mobility spectrometry
07/15/2004US20040136871 Method for detecting and compensating an underdosage of test strips
07/15/2004US20040136866 Thin semiconductors ; dielectric substrate
07/15/2004US20040135996 Biosensor with an arbitrary substrate that can be characterised in photothermal deflection
07/15/2004US20040135684 Non-specific sensor array detectors
07/15/2004US20040135585 Apparatus and method for sensing particle and water concentrations in a medium